Johnson & Johnson Covid vaccine approved for general use in South Africa
Bloomberg1 April 2021
Subscribe
Johnson & Johnson’s coronavirus vaccine has been approved by South African regulators for general use days after President Cyril Ramaphosa said the country will get more than 30 million doses.
The South African Health Products Regulatory Authority has backed the single-shot candidate with conditions, spokesman Yuven Gounden said by phone on Thursday, without giving further detail.
The US drug maker’s vaccine has so far only been used in the country to inoculate health workers, and its approval is a boost to a national roll out that’s been hit by a series of delays.
3 Min Read
CAPE TOWN (Reuters) - South Africa’s medicines regulator said on Thursday that it was at an advanced stage of reviewing an emergency use application for Pfizer’s COVID-19 vaccine. A woman holds a small bottle labeled with a Coronavirus COVID-19 Vaccine sticker and a medical syringe in front of displayed Pfizer logo in this illustration taken, October 30, 2020. REUTERS/Dado Ruvic/File Photo
“Pfizer has engaged with SAHPRA via two regulatory pathways, that is registration for full commercial market access and Section 21 authorisation. The Section 21 application is in advanced stages of review,” Yuven Gounden, spokesman for the South African Health Products Regulatory Authority (SAHPRA), told Reuters.
Johnson & Johnson Covid-19 vaccine approved in SA
By Janice Kew
(Bloomberg) – Johnson & Johnson’s coronavirus vaccine has been approved by South African regulators for general use days after President Cyril Ramaphosa said the country will get more than 30 million doses.
The South African Health Products Regulatory Authority has backed the single-shot candidate with conditions, spokesman Yuven Gounden said by phone on Thursday, without giving further detail.
The U.S. drugmaker’s vaccine has so far only been used in the country to inoculate health workers, and its approval is a boost to a national roll out that’s been hit by a series of delays. The regulator last month approved the shot developed by Pfizer Inc. and BioNTech SE, though AstraZeneca Plc’s has been spurned due to concern over its limited efficacy against a variant identified in the country late last year.
Ready for rollout Johnson & Johnson Covid-19 vaccine approved Molefe Seeletsa
Picture: AFP The approval comes as South Africa is expected to receive the first batch of an order of 30 million of the same single dose J&J vaccines.
The South African Health Products Regulatory Authority (SAHPRA) has approved the Johnson & Johnson (J&J) Covid-19 vaccine for mass distribution across the country.
SAHPRA’s Yuven Gounden confirmed the approval to
The Citizen on Thursday afternoon, as South Africa is expected to receive the first batch of an order of 30 million of the single-dose J&J vaccines manufactured locally by pharmaceutical giant Aspen in Gqeberha (formerly Port Elizabeth), Eastern Cape.
Sahpra has received fewer than 200 applications for its ivermectin compassionate-use programme news24.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news24.com Daily Mail and Mail on Sunday newspapers.